Literature DB >> 8666648

Occipito-atlanto-axial fusion in Morquio-Brailsford syndrome. A ten-year experience.

A O Ransford1, H A Crockard, J M Stevens, S Modaghegh.   

Abstract

In 17 patients (eleven males, six females) with Morquio-Brailsford syndrome (mucopolysaccharidosis IV) we have used onlay femoral and tibial autografts placed posteriorly and secured to the laminae of C1 and C2 to obtain satisfactory occipito-C1/C2 posterior fusion. They were immobilised postoperatively in a halo-plaster body jacket for four months. The age at operation varied between three and 28 years. Those with myelopathic symptoms of recent onset made some recovery, but severely myelopathic patients showed little or no recovery. We advise prophylactic occipitocervical fusion in these patients since the cartilaginous dens is not strong enough to ensure atlanto-axial mechanical stability.

Entities:  

Mesh:

Year:  1996        PMID: 8666648

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  32 in total

1.  Anaesthetic considerations of adults with Morquio's syndrome - a case report.

Authors:  Anne Marie McLaughlin; Muhammad Farooq; Maria B Donnelly; Kieran Foley
Journal:  BMC Anesthesiol       Date:  2010-02-26       Impact factor: 2.217

Review 2.  Mucopolysaccharidosis IVA and glycosaminoglycans.

Authors:  Shaukat Khan; Carlos J Alméciga-Díaz; Kazuki Sawamoto; William G Mackenzie; Mary C Theroux; Christian Pizarro; Robert W Mason; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2016-11-29       Impact factor: 4.797

3.  Outcomes from 18 years of cervical spine surgery in MPS IVA: a single centre's experience.

Authors:  A Broomfield; K Zuberi; J Mercer; G Moss; N Finnegan; P Hensman; R Walker; S Bukhari; N B Wright; F Stewart; S A Jones; R Ramirez
Journal:  Childs Nerv Syst       Date:  2018-06-26       Impact factor: 1.475

4.  The skeletal phenotype of intermediate GM1 gangliosidosis: Clinical, radiographic and densitometric features, and implications for clinical monitoring and intervention.

Authors:  Carlos R Ferreira; Debra S Regier; Robin Yoon; Kristen S Pan; Jean M Johnston; Sandra Yang; Jürgen W Spranger; Cynthia J Tifft
Journal:  Bone       Date:  2019-11-06       Impact factor: 4.398

Review 5.  Morquio A syndrome: diagnosis and current and future therapies.

Authors:  Shunji Tomatsu; Eriko Yasuda; Pravin Patel; Kristen Ruhnke; Tsutomu Shimada; William G Mackenzie; Robert Mason; Mihir M Thacker; Mary Theroux; Adriana M Montaño; Carlos J Alméciga-Díaz; Luis A Barrera; Yasutsugu Chinen; William S Sly; Daniel Rowan; Yasuyuki Suzuki; Tado Orii
Journal:  Pediatr Endocrinol Rev       Date:  2014-09

6.  Obstructive airway in Morquio A syndrome, the past, the present and the future.

Authors:  Shunji Tomatsu; Lauren W Averill; Kazuki Sawamoto; William G Mackenzie; Michael B Bober; Christian Pizarro; Christopher J Goff; Li Xie; Tadao Orii; Mary Theroux
Journal:  Mol Genet Metab       Date:  2015-09-21       Impact factor: 4.797

7.  Early neurosurgical intervention in spondyloepiphyseal dysplasias.

Authors:  E Al-Shail; A Al-Odaib; P T Ozand
Journal:  Childs Nerv Syst       Date:  2005-08-20       Impact factor: 1.475

8.  Development of a Scoring System to Evaluate the Severity of Craniocervical Spinal Cord Compression in Patients with Mucopolysaccharidosis IVA (Morquio A Syndrome).

Authors:  Christian Möllmann; Christian G Lampe; Wibke Müller-Forell; Maurizio Scarpa; Paul Harmatz; Manfred Schwarz; Michael Beck; Christina Lampe
Journal:  JIMD Rep       Date:  2013-04-12

9.  Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI.

Authors:  David A Stevenson; Kyle Rudser; Alicia Kunin-Batson; Ellen B Fung; David Viskochil; Elsa Shapiro; Paul J Orchard; Chester B Whitley; Lynda E Polgreen
Journal:  J Pediatr Rehabil Med       Date:  2014

10.  Progressive acetabular dysplasia in a boy with mucopolysaccharoidosis type IV A (Morquio syndrome): a case report.

Authors:  Ali Al Kaissi; Klaus Klaushofer; Franz Grill
Journal:  Cases J       Date:  2008-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.